Cyclacel Pharmaceuticals to Release Second Quarter 2017 Financial Results
BERKELEY HEIGHTS, N.J., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of …